CryoPort Inc (CYRX)

[H2R]

$2M - $28M per (additional) commercial product support!

Jacob Johnson

Got it. Thanks for that, Robert and Mark. And then I guess this is my follow-up, just a kind of big picture question that you used to talk about $2 million to $20 million of revenues per commercial approval. I think that moved to $2 million to $28 million with the CRYOPDP and the MVE deals. you've owned these businesses, I guess for almost a year now. Can you just - it is almost $2 million to $28 million, so the expectation or have you found some additional opportunities that maybe, I guess maybe, give you more confidence in it or think that maybe, $2 million to $28 million something larger than that?

Robert Stefanovich

No. those ranges are not changing, Jacob and these therapies are just beginning to ramp. So, we're confident with our customers.

Based on the clinical stage in Phase 3 (69) and a percentage of success, say 70% or whatever number you pick, one can extrapolate the revenue curve. And then the 265 in Phase 2 with a % -> Phase 3 and a % -> commercial.

Best of luck with your investments!